Quantcast


Last updated: February 27. 2014 12:39PM - 229 Views
Associated Press



Story Tools:

Font Size:

Social Media:

(AP) A lawyer for two drug companies told the Arkansas Supreme Court that the state improperly relied on federal regulations in a lawsuit that resulted in a $1.2 billion award over the companies' marketing of an antipsychotics drug.


The state's attorneys countered during Thursday's hearing before the high court that Johnson & Johnson and a subsidiary were properly penalized for improper marketing of the drug Risperdal.


A Pulaski County jury ruled against the companies in 2012.


The companies also argued that the state brought the case under a Medicaid fraud law when there were no indications of improper reimbursements.


Sixty-five legislators filed a friend of the court brief saying the law was properly applied.


Johnson & Johnson separately agreed to a $2.2 billion federal settlement on similar claims.


Associated Press
Comments
All user comments are subject to our Terms of Service. Users may flag inappropriate comments.
comments powered by Disqus



Featured Businesses


Poll



Info Minute



Gas Prices

Wilkes-Barre Gas Prices provided by GasBuddy.com